Estrongenic Steroid Hormones in Lung Cancer

Seminars in Oncology

Volumn 41, Issue 1, 2014, Pages 5-16

  Siegfried, Jill M ^a,b   Stabile, Laura P ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; AROMATASE; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HUMANS; LUNG NEOPLASMS; MALE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 84894504501     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2013.12.009     Document Type: Article

References (79)

1. J.D. Blaustein Steroid hormone receptors: long- and short-term integrators of the internal milieu and the external environment Horm Metab Res 44 2012 563 568
2. S. Mosselman, J. Polman, and R. Dijkema ER beta: identification and characterization of a novel human estrogen receptor FEBS Lett 392 1996 49 53
3. A.H.Y. Lin, R.W.S. Li, and E.Y.W. Ho et al. Differential ligand binding affinities of human estrogen receptor-α isoforms PLOS One 8 2013 e63199
4. Y.K. Leung, P. Mak, and S. Hussan et al. Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling Proc Natl Acad Sci USA 103 2006 13162 13167
5. A.M. Shaaban, A.R. Green, and S. Karthik et al. Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients Clin Cancer Res 14 2008 5228 5235
6. A.W. Brandenberger, M.K. Tee, and J.Y. Lee et al. Tissue distribution of estrogen receptors alpha (ER-α) and beta (ER-β) mRNA in the midgestational human fetus J Clin Endocrin Metab 82 1997 3509 3512
7. C. Patrone, T.N. Caael, and K. Pettersson et al. Regulation of postnatal lung development and homeostasis by estrogen receptor β Mol Cell Biol 23 2003 8542 8552
8. A. Morani, R.P. Barros, and O. Imamov et al. Lung dysfunction causes systemic hypoxia in estrogen receptor beta knockout (ERbeta-/-) mice Proc Natl Acad Sci USA 103 2006 7165 7169
9. A.D. Benninghoff, and D.E. Williams The role of estrogen receptor β in transplacental cancer prevention by indole-3-carbinol Cancer Prev Res 6 2013 339 348
10. J.G. Lemmen, R.J. Arends, and A.L. van Boxtel et al. Tissue-and time-dependent estrogen receptor activation in estrogen reporter mice J Mol Endocrinol 32 2004 689 701
11. P. Ciana, G. DiLuccio, and S. Belcredito et al. Engineering of a mouse for the in vivo profiling of estrogen receptor activity Mol Endocrinol 15 2001 1104 1113
12. L.P. Stabile, A.L. Davis, and C.T. Gubish et al. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen Cancer Res 62 2002 2141 2150
13. C.T. Wu, Y.L. Chang, and J.Y. Shih et al. The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers J Thorac Cardiovasc Surg 130 2005 979 986
14. A.G. Schwartz, G.M. Prysak, and V. Murphy et al. Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex Clin Cancer Res 11 2005 7280 7287
15. H. Kawai, A. Ishii, and K. Washiya et al. Combined overexpression of EGFR and estrogen receptor alpha correlates with a poor outcome in lung cancer Anticancer Res 25 2005 4693 4698
16. B.G. Skov, B.M. Fischer, and H. Pappot Oestrogen receptor b over expression in males with non-small cell lung cancer is associated with better survival Lung Cancer 59 2008 88 94
17. J.T. Moore, D.D. McKee, and K. Slent-Kesler et al. Cloning and characterization of human estrogen receptor beta isoforms Biochem Biophys Res Commun 247 1998 75 78
18. S. Ogawa, S. Inous, and T. Watanabe et al. Molecular cloning and characterization of human estrogen receptor beta: a potential inhibitor of estrogen action in human Nucleic Acids Res 26 1998 3505 3512
19. P.A. Hershberger, A.C. Vasquez, and B. Kanterewicz et al. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands Cancer Res 65 2005 1598 1605
20. P.A. Hershberger, L.P. Stabile, and B. Kanterewicz et al. Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells J Steroid Biochem Mol Biol 116 2009 102 109
21. J. Mazieres, I. Rouquette, and B. Lepage et al. Specificities of lung adenocarcinoma in women who have never smoked J Thorac Oncol 8 2013 923 929
22. L.P. Stabile, S. Dacic, and S.R. Land et al. Combined analysis of estrogen receptor b-1 and progesterone receptor expression identifies lung cancer patients with poor outcome Clin Cancer Res 17 2011 154 164
23. S. Sethi, M. Coti, and F. Lonardo Expression of estrogen receptor beta 1 but not estrogen receptor beta 2 or alpha is linked to worse prognosis in stage I adenocarcinoma, in women, in a large epidemiological cohort but not in a smaller, single hospital based series US Canadian Acad Pathol 2010 abstract 1843
24. S. Navaratnam, G. Skliris, and G. Qing et al. Differential role of estrogen receptor beta in early versus metastatic non-small cell lung cancer Horm Cancer 3 2012 93 100
25. Z. Liu, Y. Liao, and H. Tang et al. The expression of estrogen receptors b2,5 identifies and is associated with prognosis in non-small cell lung cancer Endocrine 44 2013 517 524
26. G. Zhang, N. Yanamala, and K.L. Lathrop et al. Ligand-independent antiapoptotic function of estrogen receptor-beta in lung cancer cells Mol Endocrinol 24 2010 1737 1747
27. D.C. Simoes, A.M. Psarra, and T. Mauad et al. Glucocorticoid and estrogen receptors are reduced in mitochondria of lung epithelial cells in asthma PLoS One 7 2012 e39183
28. K.S. Albain, J.J. Crowley, and M. Le Blanc et al. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience J Clin Oncol 9 1991 1618 1626
29. K.A. Moore, C.M. Mery, and M.T. Jaklitsch et al. Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancer Ann Thorac Surg 766 2003 1789 1795
30. H.A. Wakelee, S.E. Dahlberg, and J.A. Schiller et al. Menopausal status of women may affect survival in advanced NSCLC: analysis of recent Eastern Cooperate Oncology Group (ECOG) studies using age of 60 years or older as a surrogate marker: P1-052 J Thorac Oncol 2 2007 S570
31. A.K. Ganti, A.E. Sahmoun, and A.W. Panwalkar et al. Hormone replacement therapy is associated with decreased survival in women with lung cancer J Clin Oncol 24 2006 59 63
32. Schwartz AG Chelbowski, and H. Wakelee et al. Estrogen plus progestin and lung cancer in postmenopausal women Lancet 375 2009 1243 1251
33. C.G. Slatore, J.W. Chien, and D.H. Au et al. Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study J Clin Oncol 28 2010 1540 1546
34. M.B. Schabath, X. Wu, and R. Vassilopoulou-Sellin et al. Hormone replacement therapy and lung cancer risk: a case-control analysis Clin Cancer Res 10 2004 113 123
35. A.G. Schwartz, A.S. Wenzlaff, and G.M. Prysak et al. Reproductive factors, hormone use, estrogen receptor expression and risk of non-small cell lung cancer in women J Clin Oncol 25 2007 5785 5792
36. C. Bouchardy, S. Benhamou, and R. Schaffar et al. Lung cancer mortality risk among breast cancer patients treated with anti-estrogens Cancer 117 2011 1288 1295
37. S.A. Lother, G.A. Harding, and G. Musto et al. Antiestrogen use and survival of women with non-small cell lung cancer in Manitobe, Canada Horm Cancer 2013 [Epub ahead of print]
38. R.J. Pietras, and D.C. Marquez-Garban Membrane-associated estrogen receptor signaling pathways in human cancers Clin Cancer Res 13 2007 4672 4676
39. Z. Hammoud, B. Tan, and S. Badve et al. Estrogen promotes tumor progerssion in a genetically defined mouse model of lung adenocaricoam Endocr Relat Cancer 15 2008 475 483
40. L.P. Stabile, J.S. Lyker, and C.T. Gubish et al. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects Cancer Res 65 2005 1459 1470
41. C. Martel, M.H. Melner, and D. Gagne et al. Widespread tissue distribution of steroid sulfatase, 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD), 17 beta-HSD 5 alpha-reductase and aromatase activities in the rhesus monkey Mol Cell Endocrinol 104 1994 103 111
42. T. Price, J. Aitken, and E.R. Simpson Relative expression of aromatase cytochrome P450 in human fetal tissues as determined by competitive polymerase chain reaction amplification J Clin Endocrinol Metab 74 1992 879 883
43. H. Niikawa, T. Suzuki, and Y. Miki et al. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma Clin Cancer Res 14 2008 4417 4426
44. O.K. Weinberg, D.C. Marquez-Garban, and M.C. Fishbein et al. Aromatase inhibitors in human lung cancer therapy Cancer Res 65 2005 11287 11291
45. L.P. Stabile, M.E. Rothstein, and D.E. Cunningham et al. Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens Carcinogenesis 33 2012 2181 2189
46. R.C. Coombes, E. Hall, and L.J. Gibson et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer N Engl J Med 35011 2004 1081 1092
47. V. Mah, D.B. Seligson, and A. Li et al. Aromatase expression predicts survival in women with early-stage non small cell lung cancer Cancer Res 67 2007 10484 10490
48. M.K. Verma, Y. Miki, and K. Abe et al. Intratumoral localizastion and activity of 17beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer: a potent prognostic factor J Transl Med 11 2013 167
49. P. Thomas, Y. Pang, and J. Dong et al. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells Endocrinology 146 2005 624 632
50. V.R. Jala, B.B.N. Radde, and B. Haribabu et al. Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer BMC Cancer 12 2012 624
51. T. Rajkumar, and W.J. Gullick The type I growth factor receptors in human breast cancer Breast Cancer Res Treat 29 1994 3 9
52. Y. Yarden, and M.X. Sliwkowski Untangling the ErbB signaling network Nat Rev Mol Cell Biol 2 2001 127 137
53. G. Selvaggi, S. Novello, and V. Torri et al. Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer Ann Oncol 151 2004 28 32
54. D.C. Marquez-Garban, and H.-W. Chen et al. Estrogen receptor signaling pathways in human non-small cell lung cancer Steroids 72 2007 135 143
55. E.B. Garon, R.J. Pietras, and R.S. Finn et al. Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small cell lung cancer J Thorac Oncol 8 2013 270 278
56. J.M. Siegfried, C.T. Gubish, and M.E. Rothstein et al. Combining the multitargeted kinase inhibitor vandetanib with the antiestrogen fulvestrant enhances its antitumor effect in non-small cell lung cancer J Thorac Oncol 7 2012 485 495
57. L. Shen, Z. Li, and S. Shen et al. The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromtase inhibitor anastrozole in non-small cell lung cancer cell lines Lung Cancer 78 2012 193 200
58. S. Kato, H. Endoh, and Y. Masuhiro et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase Science 270 1995 1491 1494
59. H. Tang, Y. Liao, and G. Chen et al. Estrogen upregulates the IGF-1 signaling pathway in lung cancer through estrogen receptor-B Med Oncol 29 2012 2640 2648
60. H. Tang, Y. Liao, and L. Xu et al. Estrogen and insulin-like growth factor 1 synergistically promote the development of lung adenocarcinoma in mine Int J Cancer 133 2013 2473 2482
61. S.H. Yang, L.E. Mechanic, and P. Yang et al. Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer Clin Cancer Res 11 2005 2106 2110
62. N. Nose, K. Sugio, and T. Oyama et al. Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung J Clin Oncol 27 2009 411 417
63. A.M. Traynor, J.H. Schiller, and L.P. Stabile et al. Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer Lung Cancer 64 2009 51 59
64. th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10 Washington DC. Philadelphia (PA): AACR; 2013; abstract 4664.
65. S. Okubo, J. Kurebayashi, and T. Otsuki et al. Additive antitumour effect of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa, ZD1839) and the antioestrogen fulvestrant (Faslodex, ICI 182,780) in breast cancer cells Br J Cancer 901 2004 236 244
66. J.M. Su, H.K. Hsu, and H. Chang et al. Expression of estrogen and progesterone receptors in non-small-cell lung cancer: immunohistochemical study Anticancer Res 16 1996 3803 3806
67. U. Kaiser, J. Hofmann, and M. Schilli et al. Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer Int J Cancer 67 1996 357 364
68. L. Di Nunno, L.G. Larsson, and J.J. Rinehart et al. Estrogen and progesterone receptors in non-small cell lung cancer in 248 consecutive patients who underwent surgical resection Arch Pathol Lab Med 124 2000 1467 1470
69. M.G. Raso, C. Behrens, and M.H. Herynk et al. Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation Clin Cancer Res 15 2009 5359 5368
70. H. Ishibashi, T. Suzuki, and S. Suzuki et al. Progesterone receptor in non-small cell lung cancer-a potent prognostic factor and possible target for endocrine therapy Cancer Res 65 2005 6450 6458
71. K. Abe, Y. Miki, and K. Ono et al. Highly concordant coexpression of aromatase and estrogen receptor beta in non-small cell lung cancer Hum Pathol 41 2010 190 198
72. M. Xie, S. You, and Q. Chen et al. Progesterone inhibits the migration and invasion of A549 lung cancer cells through membrane progesterone receptor a-mediated mechanisms Oncol Rep 29 2013 1873 1880
73. C.A. Lange, T. Shen, and K.B. Horwitz Phosphorylation of human progesterone receptors at serine-294 my mitogen-activated protein kinase signals their degradation by the 26S proteasome Proc Natl Acad Sci USA 97 2000 1032 1037
74. X. Cui, Z. Lazard, and P. Zhang et al. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2 Oncogene 22 2003 6937 6941
75. G. Sutton Hormonal aspects of endometrial cancer Curr Opin Obstet Gynecol 2 1990 69 73
76. R.M. Kelley, and W.H. Baker Progestational agents in the treatment of carcinoma of the endometrium N Engl J Med 264 1961 216 222
77. A.M. Egloff, M.E. Rothstein, and R. Seethala et al. Cross-talk between estrogen receptor and epidermal growth factor receptor in head and neck squamous cell carcinoma Clin Cancer Res 15 2009 6529 6540
78. K.D. Somers, M. Koening, and G.L. Schechter Growth of head and neck squamous cell carcinoma in nude micd: potentialtion of laryngeal carcinoma by 17β-estrodiol J Natl Cancer Inst 80 1988 688 691
79. A. Barzi, A. Lenz, and M. LaBonte et al. Molecular pathways: estrogen pathway in colorectal cancer Clin Cancer Res 19 2013 5842 5848